After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
BioAge Labs Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of BioAge Labs Inc is $452.49M. A total of 0.63 million shares were traded on the day, compared to an average of 446.33K shares.
In the most recent transaction, RUBIN PAUL D bought 7,433 shares of BIOA for 13.41 per share on Jan 02 ’26. In a previous transaction on Dec 09 ’25, RUBIN PAUL D sold 18,000 shares at 12.00 per share. BIOA shares that Chief Medical Officer owns now total 0.
Among the insiders who bought shares, RUBIN PAUL D acquired of 18,000 shares on Dec 09 ’25 at a per-share price of $12.00. In another insider transaction, RUBIN PAUL D sold 68,897 shares at $10.19 per share on Dec 04 ’25. Company shares held by the Chief Medical Officer now total 0.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, BIOA has a high of $14.46 and a low of $2.88.
As of this writing, BIOA has an earnings estimate of -$0.65 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of -$0.53 per share and a lower estimate of -$0.75. The company reported an EPS of -$1.75 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BIOA is Buy with a score of 3.40.
